Arcus Biosciences Inc (RCUS) — Capital Reinvestment Ratio
Arcus Biosciences Inc (RCUS) has a Capital Reinvestment Ratio of 0.04x as of September 2024, meaning it reinvests 0% of its operating cash flow ($26.00 Million) in capital expenditures ($1.00 Million). Check Arcus Biosciences Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Arcus Biosciences Inc Capital Reinvestment Ratio (2020–2022)
This chart tracks Arcus Biosciences Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Arcus Biosciences Inc operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Arcus Biosciences Inc (2020–2022)
Year-by-year Capital Reinvestment Ratio for Arcus Biosciences Inc from 2020 to 2022. See free cash flow generation of Arcus Biosciences Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.01x | $438.00 Million | $6.00 Million | ▼ -50.2% |
| 2020 | 0.03x | $111.17 Million | $3.06 Million | — |